The QualityStocks Daily Newsletter for Monday, June 14th, 2010 Blog  |  Video  |  Market Basics  |  Quotes & News  |  Clients  |  Partners  |  About Us  |  Contact Us

Today's Top 3 Investment Newsletters


Nebula Stock (GBHL)


All Penny Stocks (POPN)


Research Driven Investor (FRDM)

The QualityStocks Daily

Franklin Wireless Corp. (FKWL)

OTC Picks reported earlier on Franklin Wireless Corp. (FKWL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Headquartered in San Diego, California, Franklin Wireless Corp. designs and sells broadband high-speed wireless data communication products such as third generation (3G) and fourth generation (4G) wireless modems and modules. The Company focuses primarily on wireless broadband Universal Serial Bus (USB) modems. These USB modems provide a convenient way for wireless subscribers to connect to broadband networks with any laptop or desktop PC. Founded in 1982, Franklin Wireless Corp. trades on the OTC Bulletin Board.

The Company positions their products at the convergence of wireless communications, mobile computing and the Internet. Recently, Franklin Wireless opened their first regional office in Asia. They also expanded their R&D and product design capabilities through a strategic investment in South Korea based Diffon Corporation.

Franklin Wireless Corp. announced the global launch of their M210 module this past March. This is a single-mode module using EVDO (Evolution Data-Optimized) Rev. A technology.  They expect to sell this device to original equipment manufacturers (OEMs) or others who seek a reliable embedded module solution for their wireless data applications.

Additionally, in March, Franklin Wireless Corp. announced the availability of their R536 WiMax Wave II embedded Wi-Fi hotspot router for U.S., Latin American and Caribbean markets. The R536 device features a replaceable and rechargeable lithium-ion battery. It also features an intuitive web-based user interface that allows for simple set up and network configuration.

The Company's new WiMax hotspot router is smaller and weighs less (approximately 2.46 ounces or 70 grams) than other products available in the market today.  The R536 is a 2.5 GHz band device that features 802.11 b/g Wi-Fi. It supports Windows, Macintosh and Linux operating systems and does not require special software to access network connections.

The Company also announced in March the launch of their new U600 dual-mode WiMAX/CDMA modem. Franklin Wireless is the world's first supplier of dual-mode (CDMA/WiMAX) modem products. The U600 is their third-generation in their series of dual-mode modems. It has a small, slim, compact design, and provides a flexible way for mobile users to connect to wireless broadband networks. It operates with Windows, Macintosh and Linux operating systems.

Last month, Franklin Wireless Corp. and Samsung Electro-Mechanics Co., Ltd. announced the signing of a manufacturing agreement for broadband modules. Samsung will manufacture and supply Franklin Wireless with a new broadband module. This module will be a vital component for the Company's dual-mode 3G/4G USB modems in the near future.  Franklin Wireless President OC Kim and Samsung Electro-Mechanics Co., Ltd. Senior Vice President H.B. Lee signed the contract recently.

In addition, last month, Franklin Wireless Corp. announced record revenue and net income for the third quarter of fiscal 2010 ended March 31, 2010. They reported a sales increase of 854 percent to $31.6 million for the quarter ending March 31, 2010, compared with $3.3 million in sales for the corresponding period of 2009. Net income increased to $1.3 million for the three-month period ending March 31, 2010, compared with $64,863 for the same period in 2009. Cash and cash equivalents were $9.1 million at the end of the third quarter fiscal 2010, compared to $5.2 million at the end of the second quarter of fiscal 2010 and $6.3 million a year ago.

Franklin Wireless Corp. (FKWL) closed Monday's trading session at $2.17 up 5.34 percent. Volume was 13,000.

SwissINSO Holding Inc. (SWHN)

Last week, Daily Profit and Street Authority Financial reported on SwissINSO Holding Inc. (SWHN). Schaeffer's, Market FN, Investment House, Another Winning Trade, The Best Newsletters, Bellwether Report, and M2 Communications did earlier, and we highlight the Company today, here at the QualityStocks Daily Newsletter.

Founded in 2006, SwissINSO Holding Inc. utilizes their intellectual property assets to provide environmentally friendly, innovative solar energy solutions and related technology to meet growing global needs. Their corporate goal is to become a world leader in turnkey solutions using renewable energy for the purification and desalination of water and the air cooling & heating of buildings. SwissINSO Holding Inc. trades on the OTC Bulletin Board and they have their headquarters in Lausanne, Switzerland.

The Company's management team has extensive experience in market and business development in their targeted market niches via private industry, NGO's, and global government development agencies. Their product strategy is to provide complete solutions to the marketplace that drive key customer value immediately, are sustainable, and contribute to global energy saving. Critical to their strategy is how their proprietary embedded technologies provide clear competitive advantage, while offering efficient green solutions.

SwissINSO developed a self-contained mobile water purification and bottling unit (KRYSTALL™) using an exclusive membrane filtration system and powered by highly efficient photovoltaic solar panels. Each unit will be energy self-sufficient with minimal operational and maintenance costs. The Company will also provide a unique, environmentally friendly air-conditioning solution (KLYMAA™) using revolutionary colored glazed cladding solar panels. These panels are used to form either a full or a partial solar envelope around the building. This maximizes the heat capturing capability of the panels

In late April, SwissINSO Holding Inc. announced the successful launch of KRYSTALL™. This is the Company's first fully solar powered water purification product. KRYSTALL™ products will be available in a number of configurations. They will be capable of purifying over 100,000 liters of brackish water and 50,000 liters of seawater daily into high-quality drinking water.

The units are completely turnkey and self-contained in two 40-foot containers. They can be fitted with an optional automatic bottling line. Each unit is fully autonomous, powered by state-of-the-art photovoltaic panels that also charge batteries for operation of the unit during darkness or cloudy conditions.

SwissINSO Holding Inc. (SWHN) closed Monday's trading session at $1.44 up 2.86 percent. Volume was 421,690.

InfoLogix, Inc. (IFLG)

Bull Rally, Hot OTC, Cool Penny Stocks, Stock Rich, and Trading Markets reported this month on InfoLogix, Inc. (IFLG), Internet News, OTC Picks, Street Insider, Greenbackers, Market Wrap Daily did earlier, and we highlight the Company, here at the QualityStocks Daily Newsletter.

Trading on the NASDAQ Capital Market, InfoLogix, Inc. is a single-source provider of complete enterprise mobility solutions for the healthcare and commercial industries. The Company uses the industry's most advanced technologies to increase the efficiency, accuracy, and transparency of complex business and clinical processes.  Founded in 2001, InfoLogix, Inc. has their headquarters in Hatboro, Pennsylvania.

The Company has delivered solutions to more than 1,400 hospitals across North America. Their team of healthcare/IT consultants each has a minimum of 20 years' combined experience in the clinical and technology worlds. In the commercial realm, over 800 enterprises have turned to InfoLogix for expertise in mobility solutions. This includes asset management, fleet management, inventory management and point of sale.

InfoLogix, Inc. has 19 issued patents. The Company provides mobile managed solutions, on-demand software applications, mobile infrastructure products, and strategic consulting services to more than 2,000 clients in North America. These clients include Kraft Foods, Merck and Company, General Electric, Kaiser Permanente, MultiCare Health System, and Stanford School of Medicine.

On May 26, 2010, InfoLogix, Inc. announced that their Board of Directors initiated a review of strategic alternatives. This is to address various financial and operational challenges facing the Company. It is also to identify the most effective means for optimizing value for stockholders. This includes reviewing proposals for additional financing, further restructuring the Company's debt and effecting one or more strategic transactions.

The Board met and formed a special committee of independent directors. The Committee is working with financial advisors to assist in their review of strategic alternatives. Upon completion of their review, they will make their recommendation to the Board.

On June 2, 2010, Healthcare Informatics Associates (HIA), an InfoLogix, Inc. company, announced that they successfully assisted Hilo Medical Center in Hilo, Hawaii. They assisted them in going live with Phase 1 of one of the nation's first MEDITECH 6.0 electronic medical record (EMR) implementations and becoming the first hospital on the island of Hawaii to bring the EMR to the patient's bedside. With the implementation of Phase 1 of the engagement going live, Hilo has advanced from paper-based systems toward an automated EMR system.

As part of the strategy to mobilize Hilo's EMR initiatives, InfoLogix and HIA also have a multi-year agreement in place, announced in 2009. This agreement is to provide wireless managed services across the Hilo Medical Center facility.  

InfoLogix, Inc. (IFLG) closed today's trading at $6.90 up 91.14 percent. Volume was 8,405,883.

Netlist Inc. (NLST)

Today, Bull Rally, Hot OTC, Penny Invest, Momentum Traders, Stockpalooza, Penny Trader, Stock Rich, Stock Egg, Cool Penny Stocks, Microcap Voice, and Greenbackers reported on Netlist Inc. (NLST), and we do as well, here at the QualityStocks Daily Newsletter.

Trading on the NASDAQ Global Market, Netlist, Inc. designs and manufactures high-performance, logic-based memory subsystems. These are for the server and high-performance computing and communications markets. Founded in 2000, the Company has their corporate headquarters in Irvine, California. They have manufacturing facilities in Suzhou, People's Republic of China.
The Company develops memory subsystems for applications in which high-speed, high-capacity memory, enhanced functionality, small form factor, and heat dissipation are key requirements.  These applications include tower-servers, rack-mounted servers, blade servers, high-performance computing clusters, engineering workstations, and telecommunication equipment. 

Netlist specializes in bridging the widening gap between the system OEM's requirements and the capabilities of the IC manufacturer. Their patented memory subsystem technologies overcome density, performance, and cost limitations. They blend commodity components with their inherent deficiencies into highly reliable, optimized memory solutions. The Company pioneered ideas such as embedding passives into printed circuit boards to free up board real estate, doubling densities via 4-rank double data rate (DDR) technology, and other off-chip technology advances that result in improved performance and lower costs compared to conventional memory.

On June 11, 2010, Netlist, Inc. announced that their HyperCloud™ memory module has been selected to run on Viglen servers to support High Performance Computing (HPC) applications. Viglen is a leading British manufacturer and provider of IT solutions within the education and public sector. HyperCloud takes advantage of the benefits of Netlist's patented load reduction and rank multiplication technology to improve overall server performance. HyperCloud serves as a cost-effective solution by lowering operating expenses for datacenters. It offers higher capacity to support memory intensive workloads, such as HPC simulations.

"To be selected by Viglen exemplifies the value we provide with our HyperCloud memory module," said C.K. Hong, Netlist Chief Executive Officer. "Our HyperCloud technology is a key enabler of server efficiency and offers a unique value-add for companies deploying new IT infrastructures. We are pleased to enhance performance on Viglen servers and look forward to continuing to offer compelling memory solutions to address the computing demands."

Netlist Inc. (NLST) closed Monday's trading at $2.88 up 17.55 percent. Volume was 7,482,188.

Tofutti Brands Inc. (TOF)

Today we choose to highlight Tofutti Brands Inc. (TOF), here at the QualityStocks Daily Newsletter.

Tofutti Brands Inc. principally engages in the development, production, and marketing of TOFUTTI brand soy-based, dairy-free frozen desserts, soy-based dairy free cheese products and other soy-based, dairy-free food products.  The Company's products sell in grocery stores, supermarkets, health and convenience stores throughout the U.S. and in approximately twenty-five other countries. Founded in 1981, Tofutti Brands Inc. trades on the NYSE Amex. They have their corporate headquarters in Cranford, New Jersey.

The Company offers nondairy soy-based products, including frozen desserts, nondairy cheeses and spreads, other frozen food products, and various dry grocery items. Their frozen desserts include soft serve mixes, frozen sandwiches, ice cream sandwiches, and stick novelties. Their nondairy cheese products include cream cheese, sour cream, and cheese slices. Their other food products consist of pizza and frozen crepes.

Last month, the Company announced their results for the thirteen-week period ended April 3, 2010. Financial highlights for the quarter include revenues of approximately $4.6 million compared to $4.2 million in the first quarter of 2009. Operating income in the first quarter was $475,000 compared to $253,000 in the first quarter of 2009. Net income for the first quarter was $275,000 compared to $152,000 in the first quarter of 2009.

On June 10, 2010, Tofutti Brands Inc. announced the results of their annual meeting of shareholders and the development of three new food products. Mr. David Mintz, the Company's Chief Executive Officer and Chairman of the Board of Directors announced the development of the new dairy-free food products.

The first product is the first commercially available nondairy and gluten-free ricotta cheese product. The second product is a dairy-free, sugar-free, frozen dessert. This dessert incorporates Stevia as the sweetening agent. Tofutti Brands Inc. believes this is the first frozen dessert to use the natural Stevia as a sweetener.

Mr. Mintz also announced the development of a newly re-formulated frozen pizza. This frozen pizza has a dairy-free, trans fat-free cheese topping. The expectation is that all three products will be available on grocery shelves within the next six months.

Tofutti Brands Inc. (TOF) closed Monday's session at $3.17 up 11.62 percent. Volume was 45,289.

GEROVA Financial Group Ltd. (GFC)

Today we are highlighting GEROVA Financial Group Ltd. (GFC), here at the QualityStocks Daily Newsletter.

Founded in 2008, GEROVA Financial Group, Ltd. is an international reinsurance holding company. The Company has operating insurance subsidiaries in Bermuda, Barbados, and Ireland. GEROVA underwrites insurance risks that they believe will produce favorable long-term returns on shareholder equity.

The Company believes that they have opportunities to deploy shareholder capital to acquire high quality assets at less than market value and opportunities to gather additional assets by providing reinsurance capacity to primary insurers that are under writing capacity pressure. GEROVA Financial Group, Ltd. focuses primarily on life and annuity reinsurance.

Last month, GEROVA Financial Group, Ltd. reported that they established new headquarters for their insurance operations in Hamilton, Bermuda.  The new offices are the global headquarters for GEROVA Holdings, Ltd., and for the Company's insurance subsidiaries.  The offices are in Cumberland House, in the central business district of Hamilton. The Company's headquarters were in George Town, the Cayman Islands, previously.

The Company believes that Bermuda is an attractive location for conducting their insurance operations. This is because Bermuda has a strong locally based insurance and reinsurance infrastructure, and a deep pool of local insurance talent. Bermuda also has excellent availability of cost effective third-party services providers, economic and political stability, as well as easy access from major East coast U.S. cities.

Last week, GEROVA Financial Group, Ltd. announced that they have been authorized to list their ordinary shares, units, and warrants on the NYSE Amex stock exchange. The Company's ordinary shares will continue to be listed under the symbol GFC, and the Company warrants and units under GFC.WS and GFC.U, respectively.

On June 10, 2010, GEROVA Financial Group, Ltd. announced that GEROVA Reinsurance, Ltd. received approval from the Bermuda Monetary Authority to be registered as a Long Term Insurer. This authorizes GEROVA Reinsurance to underwrite life and annuity reinsurance in Bermuda. GEROVA Reinsurance, Ltd. is a wholly owned subsidiary of GEROVA Holdings, Ltd.

"Approval of our Bermuda reinsurance license is an important step in growing GEROVA's insurance business," said Mr. Lou Hensley, CEO of GEROVA Holdings, Ltd. "Bermuda is a global reinsurance center and establishing operations here will further expand the footprint of GEROVA's insurance business."

GEROVA Financial Group Ltd. (GFC) closed Monday's trading session at $17.25 up 24.28 percent. Volume was 134,309.

Darnley Bay Resources Limited (DBL.V)

We are highlighting Darnley Bay Resources Limited (DBL.V), here at the QualityStocks Daily Newsletter.

Trading on the TSX Venture Exchange, Darnley Bay Resources Limited is a company that explores and develops an area of geophysical significance in the Northwest Territories of Canada. The Company's objectives are to secure and maintain successful financing partnerships to continue exploration for base metals, gold and diamonds that will result in the development of a profitable mining venture. Formed in 1993, Darnley Bay Resources Limited has their headquarters in Toronto, Ontario.

Darnley Bay Resources Limited's primary focus is exploration for base metals and diamonds. This is in an area surrounding the hamlet of Paulatuk, located along the shores of Darnley Bay, in the Inuvialuit Settlement Region (ISR), Northwest Territories, Canada. The area is the site of the strongest isolated gravity anomaly in North America. Initial base metal exploration resulted in the discovery of diamonds, indicating that the area is host to both metallic and non-metallic mineral deposit interests.

On April 9, 2010, Darnley Bay Resources Limited announced that the 5,980 line-km airborne gravity and magnetic survey carried out by Sander Geophysics Limited on their properties near Paulatuk, Northwest Territories was completed. The data from that survey and the Geotech VTEM surveys are undergoing processing and modeling.

The Company plans, barring unforeseen delays, to begin their drill program later this month. They are tendering their drill contract. The Company will announce the selected contractor upon conclusion of the negotiations.

The Company worked with Kavik-Axys and Aurora Geosciences. This was to complete their submission to the Inuvialuit Environmental Impact Screening Committee (EISC) for drilling and associated ground exploration activities on their properties. It went into consideration at the EISC meeting in Inuvik, June 2 to 4, 2010.

On April 19, 2010, the Company released preliminary results from the recently completed Geotech VTEM and Sander AirGRAV surveys over a large portion of their properties near Paulatuk, Northwest Territories. The Company, with the assistance of Paterson, Grant & Watson Limited, consulting geophysicists of Toronto, Canada, prepared a series of images and commentary from the field data.

The final data will have several standard processes applied by the contractors to make corrections, improve data resolution and remove topographic effects, level errors and noise. From these final data, 2D and 3D models will be prepared, and drill targets located and prioritized.

Today, Darnley Bay Resources Limited (DBL.V) closed at $0.29 up 3.57 percent. Volume was 180,000.

Banro Corporation (BAA)

Another Winning Trade, The Best Newsletters, Market FN, Investment House, OTC Picks, and Agoracom reported earlier on Banro Corporation (BAA), and we choose to highlight the Company today, here at the QualityStocks Daily Newsletter.

Trading on the NYSE Amex, Banro Corporation is a gold exploration and development company. Their corporate focus is on the development of four major, wholly owned gold projects, each with mining licenses, along the 210 kilometer-long Twangiza-Namoya gold-belt in the South Kivu and Maniema provinces of the Democratic Republic of the Congo (DRC). Banro Corporation has their headquarters in Toronto, Ontario.

The Company is beginning construction of "Phase 1" of their Twangiza project. Banro sees this project as the key to unlocking shareholder value by advancing the Company to gold production status and using this as a platform to develop their significant gold assets in a socially and environmentally responsible manner. Scheduled for completion in late 2011, the design of this gold operation is to produce 100,000-plus ounces of gold per year, with future expansion to 300,000-plus ounces of gold yearly.

Banro's four gold properties comprise 13 Exploitation Permits or PEs, with mining licenses. These properties total 2,616 square kilometers. The gold belt where they reside is in Proterozoic and Archean age rocks in the northern half of the Great Lakes sub-province. The Company's Exploitation Permits cover all the major, historical producing areas of Twangiza, Lugushwa, Namoya and Kamituga. This is where approximately 2.4 million ounces of gold were reportedly produced in the past from alluvial and hard rock sources. Gold mineralization delineated to date occurs along well-defined ridges with excellent potential for the development of open pit reserves.

In addition to their current properties, Banro in 2007 was awarded 14 exploration permits covering 2,638 square kilometers located on highly prospective ground between their Twangiza and Lugushwa projects. Applications for additional PRs contiguous to and located between their Lugushwa and Namoya projects, along with areas south of Twangiza, are pending.

Last month, Banro Corporation announced that they closed the issuance and sale of 67,100,000 common shares of the Company at a price of CDN$2.05 per share for aggregate gross proceeds of CDN$137,555,000. The Company intends to use the net proceeds from the Offering for development costs of "Phase 1" of the Twangiza project, and for additional drilling programs at the Twangiza project and other projects. The also intend to use the net proceeds for administrative and general corporate purposes of the Company.

Banro Corporation (BAA) closed Monday's trading at $1.89 up 9.25 percent. Volume was 102,694.

The QualityStocks Company Corner

Cellceutix Corp. (CTIX)

The QualityStocks Daily Newsletter would like to spotlight would like to spotlight Cellceutix Corp. (CTIX). Today, Cellceutix Corp. closed trading at $0.45, on no volume.

Cellceutix Corporation (CTIX) announced today that a new animal study of their compound for autism spectrum disorder, KM-391, once again demonstrated a positive impact on several measures of behavior associated with autism.

Cellceutix Corporation (CTIX) today announced it has drawn upon its many resources and expedited scheduling of additional pre-clinical studies of the KM-391 compound designed to treat autism. The company also announced today that it has completed two animal safety pharmacology studies for its cancer compound, Kevetrin™, both of which are required by the U.S. Food and Drug Administration (FDA) prior to filing an Investigational New Drug (IND) application

Cellceutix Corporation (CTIX) an emerging bio-pharmaceutical company, is in the early stages of receiving an influx of media attention and widespread notoriety within the pharmaceutical industry due to the promising results shown during the early development of a compound for the treatment of autism, KM-391, and the approaching Phase 1 clinical trials of Kevetrin™, the company's compound for the treatment of drug-resistant cancers. In addition to these two, Cellceutix currently manages a portfolio of six other promising compounds.

KM-391, a 100% novel compound, is revolutionary in that it addresses the core issues of autism, unlike the pharmaceuticals presently on the market which merely treat the symptoms that result from autism. Preliminary testing of KM-391 revealed that test animals showed a significant increase in serotonin uptake compared to controls with noticeable and measurable positive therapeutic changes. Cellceutix is rapidly developing KM-391 in response to the public outcries received by the company since the results of early testing had been made publicly available.

Kevetrin, Cellceutix's flagship product, is nearing Phase 1 clinical trials on humans with FDA regulated pre-clinical testing completed and the data being properly compiled for the IND application. While most cancer treatments today are derivatives of other compounds, Kevetrin is completely unique. Multidrug resistance, the principal mechanism by which strains of cancer develop resistance to chemotherapy drugs, is a major factor in the failure of many forms of chemotherapy today and represents a huge need for novel cancer treatments.

Kevetrin has been extensively studied in animal models of lung, breast, and colon cancers, targeting carcinoma strains that have proven resistant to standard therapies available on the market today with the results showing greater tumor growth delay than present therapies and strong efficacy in mouse models with increasing dosages. A successful drug for the treatment of drug-resistant cancers is purported to generate billions of dollars in annual revenues.

The Company has procured leading figures in the health and science arenas to lead its development efforts. The officers and advisors of Cellceutix include pioneers in the fields of cancer and genetics, as well as those who have been integral to mergers, acquisitions and the generation of exorbitant revenues through ground breaking therapies while holding high-level executive and research positions at industry giants such as Pfizer and Eli Lilly. Holding over a century of highly relevant experience in the pharmaceuticals industry, the team has been assembled with the specific goal of duplicating these past successes while revolutionizing much needed treatments for today's most challenging diseases. Disclaimer

Cellceutix Corp. Blog

Cellceutix Corp. News:

New Autism Drug Research by Cellceutix on Compound KM-391 Results in Significant Behavioral Changes; Chief Scientific Officer Sees Potential for Company to Emerge as Industry Leader as Pharmas Strive for Revolutionary Autism Treatments

Cellceutix Responds to Public Support by Expediting Autism Studies; Completes Two Required Safety Pharmacology Studies for Its Cancer Compound

Cellceutix CFO Discusses Autism Drug, Kevetrin(TM) and Company Progressions With CEOCFO Interviews and News

Micro Identification Technologies Inc. (MMTC)

The QualityStocks Daily Newsletter would like to spotlight Micro Identification Technologies Inc. (MMTC) Today Micro Identification Technologies Inc. closed trading at $0.0480, which was up 17.07 percent. Their volume today was 369,100 shares.

Micro Identification Technologies Inc. (MMTC) is focused on becoming a global leader in developing, supporting and marketing rapid systems and processes that detect and identify microbial organisms. For several years the company has been working on the development of a breakthrough, laser-based microbial identification technology. This technology has been designed to be extremely fast and easy to use while not relying on conventional chemical or biological processing, fluorescent tags, gas chromatography or DNA analysis.

The system works by measuring scattered light intensity as individual microbes pass through a laser beam. The intensity pattern of the scattered light is a direct consequence of the size, shape and external and internal optical characteristics of the microbe. By measuring scattered light at specific angles, MIT’s system detects and differentiates objects the size of bacteria, protozoa, yeasts and molds.

The company’s technology offers significant advantages over today’s methods of microbial detection, including lower cost, rapid results, easier use and the ability to test for multiple bacteria in one process. The system is statistically based and includes a unique MIT Microbe Library of pre-measured light scattering identifiers - or fingerprints - derived from the measurements of tens of thousands of individual microbes for each species and subspecies to be detected.

MIT’s technology has the potential to revolutionize the $5 billion rapid microbial test market by annually saving thousands of lives and tens of millions of dollars. Since 1998, the industry has had an annual expansion of 9.2 percent - with growth projections for 30 percent annually. MIT is well positioned with its cutting-edge microbial technology as demand continues to soar as a result of major health, safety and homeland security issues. Disclaimer

Micro Identification Technologies Inc. Blog

Micro Identification Technologies Inc. News:

MIT Contracts OSI Optoelectronics to Manufacture the MIT 1000 Rapid Microbial Identification System

U.S. Equity News Features Micro Identification Technologies in the Fight Against Bacteria

Micro Identification Technologies Obtains Equity Financing

NetSol Technologies, Inc. (NTWK)

The QualityStocks Daily Newsletter would like to spotlight NetSol Technologies, Inc. (NTWK). Today, NetSol Technologies, Inc. closed trading at $0.8199, which was up 6.49 percent. Their volume today was 216,641 shares.  

NetSol Technologies, Inc. (NTWK) a worldwide provider of global business services and enterprise application solutions, leverages its BestShoring(TM) practices and highly experienced resources to deliver high-quality, cost-effective solutions. The ir suite of products and services include credit and finance portfolio management systems, hospital/healthcare information management systems (HIMS), SAP consulting and services, custom development, systems integration, and technical services.

NetSol’s commitment to quality is demonstrated by its achievement of the ISO 9001, ISO 27001, and SEI (Software Engineering Institute) CMMI (Capability Maturity Model) Maturity Level 5 assessments, a distinction shared by less than 100 companies worldwide. These distinctions are a result of adhering to rigorous quality standards, resulting in the delivery of solutions that are secure, reliable, properly planned, and meticulously executed.

Serving the global financial, healthcare, insurance, energy, and technology markets, NetSol has operations, offices, and joint ventures in Adelaide, Bangkok, Beijing, Lahore, London, Riyadh, San Francisco, and San Pedro Sula. NetSol Technologies' clients include Fortune 500 manufacturers, global automakers, financial institutions, utilities, technology providers, and government agencies.

NetSol Technologies, Inc. (NTWK), is well positioned with its core product offerings as it continues to expand into new international market opportunities. Looking forward, the company is very optimistic of its short-term and long-term outlook as it sees strong growth in Asia Pacific as well as the South East Asian markets, while also envisioning unlimited potential for its niche solutions and services in the Americas. Disclaimer

NetSol Technologies, Inc. Blog

NetSol Technologies, Inc. News:

NetSol Technologies' smartOCI(TM) Search Engine Receives SAP Certification

National Automation Services, Inc. Operations and Investor Update

RedChip Visibility Initiates Research Coverage on NetSol Technologies With Strong Buy Rating

General Environmental Management Inc. (GEVI)

The QualityStocks Daily Newsletter would like to spotlight General Environmental Management Inc. (GEVI) Today, General Environmental Management Inc. closed trading at $0.09, for no change. Their volume today was 3,450 shares.

General Environmental Management Inc. (GEVI) has shifted its business focus from hazardous waste field services to the fast growing water treatment and waste-to-energy markets. Growing its business organically and developing state-of-the-art systems for operations, sales, compliance, finance, and human resources which can then be deployed at other acquired facilities, the company aims to establish a nationwide network of environmental facilities.

The strategic decision to shift the company’s focus was made after an all inclusive analysis of GEVI's opportunity in the environmental management business. Although the company could have worked through the current economic downturn and built revenue in its field services business, management believed that shareholders would be rewarded by moving the company into the higher margin, faster growing business segments.

Within the U.S. alone, the water industry is a $120 Billion market that is expected to grow at 6-7% over the next year. On a global basis, the industry size exceeds $400 billion annually and increasing with the demands of a growing world population. The global waste-to-energy market, on the other hand, is a $19.9 billion market with expected CAGR of 6.7% over the next five years.

The company’s management team believes that 2010-2011 will be years of enormous growth. GEM’s change of focus is also expected to result in margins up to eight times greater than those of the previous hazardous waste services only model. With a very selective and calculated acquisition strategy in place, GEVI is poised for continued success.


General Environmental Management Inc. Blog

General Environmental Management Inc. News:

General Environmental Management Inc. Announces $.30 EPS with First Quarter 2010 Financial Results

General Environmental Management CEO Provides Shareholders with "State of the Union" Style Communiqué

General Environmental Management Announces New Process to Stimulate Oil Production

NetSol Technologies Inc. (NTWK) Thrives Despite Economic Turbulence

When NetSol Technologies announced recently that it had secured $3 million from a major international automotive maker’s captive finance company in the Asia-Pacific region, it was just one more reflection of the very real difference between NetSol and so many other companies in the enterprise software business. In the midst of the most challenging period in that industry, perhaps since its inception, NetSol has been able to leverage its unsurpassed reputation for quality, its strong relationship with SAP technology, and its expanding worldwide connections to survive and grow. It’s this very unusual mix of strengths that make NetSol such an important investment consideration.

NetSol is a global provider of financial and other enterprise software solutions and business services to a variety of industries, including financial, healthcare, insurance, energy, and technology markets. It is one of only about 100 companies in the world to achieve ISO 9001, ISO 27001, and SEI (Software Engineering Institute) CMMI (Capability Maturity Model) Maturity Level 5 assessments. In other words, it has a major certification of quality and trust every time it walks in the door. In an industry that is all too often known for its history of customer complaints, this is a critical and hard-won badge, especially in global environments that base relationships on personal integrity and reputation.

NetSol’s signing of a combined $3 million Asia-Pacific agreement comes on the heels of an agreement with a Chinese finance company partnered with a major European bank and a multi-billion dollar Chinese financial services group. NetSol’s global perspective, including growing contacts in Asia and the Middle East, has allowed it to weather regional storms, taking advantage of stronger world opportunities. It has also worked to develop a number of strategic global alliances, such as the recent Atheeb NetSol venture with the Atheeb Group of Saudi Arabia. It’s a fundamental strategy that allows the company to better penetrate new geographical markets and industries, and to grow technologically.
As parts of the world economy start to improve, NetSol’s well planned and long cultivated mix of attributes, the same qualities that have kept it going while so many others have been buried by the recession, should allow it to flourish.

All of this is backed up by the most recent financial results, covering the company’s third quarter ended March 31, 2010. Quarterly revenues were reported as $8.9 million, up 77.8% from the $5 million reported for the same period last year, headed by a 100% sequential growth in core NetSol Financial Suite (NFS) TM license sales. Total net revenue from license fees was $3.64 million, an increase of 1,022% over the same period last year. Operating income increased to $2.58 million, compared to an operating loss of $4.26 million for the same period last year. EBITA totaled $1.9 million, or $.05 per diluted share, versus an EBITA loss of $3.5 million, or a loss of ($.013) per diluted share for the same period last year. Net income per share totaled $.02, versus a loss ($.19) for the same period a year ago. In addition, revenues for the nine months ended March 31, 2010, were up 33%, to $26.1 million, over the same nine-month period last year.

NetSol Chairman and CEO, Najeeb Ghauri, commented on the impressive numbers. “We are very pleased with our performance in the third fiscal quarter, highlighted by a 78% increase in our sales versus the same period a year ago and a return to quarterly profitability for the first time in six quarters. It is our aim to finish the year completely profitable on the fiscal year analysis. Our financial results continue to deliver material improvements in every major metric of financial health, and we are optimistic about future outlook.”

He concluded, “Our efforts to invest in our core NetSol Financial Suite (NFS)TM throughout the global economic downturn has well positioned the company to leverage the upturn in customer activity that we continue to see, particularly in China and APAC region in general. We enter the end of our fiscal year 2010 with the most positive momentum in the company’s recent history and we see increased interest among our major customers as well as new potential partners in the sector. Additionally, we see excellent opportunities for collaboration and strategic initiatives as we head to the conclusion of the fiscal year 2010.”

Cellceutix Corp.’s (CTIX) New Autism Drug Research on Compound KM-391 Results in Significant Behavioral Changes

This morning before the opening bell, Cellceutix Corp. announced that a new animal study of its compound for autism spectrum disorder, KM-391, further demonstrated a positive impact on several measures of behavior associated with autism. As announced by the company last week, Cellceutix expedited the research through a collaborative effort with InterEd Faculty of Clinical Research (IFCR) in India and the prestigious Cochin University of Science & Technology (CUSAT).

In the study, test subjects were injected with a compound to simulate autistic behaviors then injected with an oxytocin antagonist to intensify the symptoms. Test subjects were divided into four groups, oxytocin antagonist only, oxytocin antagonist plus KM-391 (10 mg/kg), placebo alone and placebo plus KM-391 (10 mg/kg). Measurements taken of autism related behaviors included: repetitive behavior, self-induced injury, sensitivity to touch, positioning correction, group dynamics, and curiosity. Through this study it was discovered that when KM-391 was given along with the oxytocin antagonist, there was a significant reduction in all 6 autism-related behaviors within 1 to 2 hours.

“We are extremely excited about the results from this phase of testing as it coincides with the previous research,” stated Dr. Krishna Menon, Chief Scientific Officer of Cellceutix. “Having been involved in the research and development of extremely successful compounds in the past, I am very encouraged by the research results that we are achieving with KM-391 and its development potential as a treatment for autism. In our testing, we have simulated specific characteristics of an autistic brain and behavioral symptoms that result from them. KM-391 has been shown to significantly improve both the physical conditions in the brain and behaviors resulting in our animal models. We now have a basis to expect to emerge as a pharma industry leader in autism.”

“With Pfizer and Novartis recently announcing that they have begun pursuing new treatments for core issues of autism, we are excited to be ahead of the curve,” added Leo Ehrlich, CFO of Cellceutix. “The latest research has significantly strengthened the previous data and this puts Cellceutix in the forefront of autism research. While we have already been receiving notoriety in the industry, we believe that this is just the beginning of great things to come for Cellceutix and its shareholders.”
Facts about autism:

•1 percent of the population of children in the U.S. ages 3-17 have an autism spectrum disorder. Prevalence is estimated at 1 in 110 births.
•More children will be diagnosed with autism this year than with AIDS, diabetes & cancer combined.
•1 to 1.5 million Americans live with an autism spectrum disorder. 1 percent of the adult population of the United Kingdom have an autism spectrum disorder.
•Fastest-growing developmental disability; 10 – 17 % annual growth.
•$60 billion estimated annual cost with 60% of costs in adult services. Cost of lifelong care can be reduced by 2/3 with early diagnosis and intervention.
•Autism receives less than 5% of the current US private research funding, and less than 1% of the total NIH budget, even though it is the most prevalent childhood disorder.

Lorus Therapeutics Inc. (LRUSF) Favorable Clinical Trial Results Presented at 15th Annual Congress of the European Hematology Association

Lorus Therapeutics Inc. is a biopharmaceutical company focused on the research and development of pharmaceutical products and technologies for the management of cancer. The company today announced the presentation of its phase II clinical trial data for LOR-2040 in combination with high dose cytarabine for the treatment of Acute Myeloid Leukemia (AML).

The data was given at the 15th Annual Congress of the European Hematology Association (EHA) in Barcelona, Spain in a presentation entitled “A Phase II Study of GTI-2040, an Antisense to Ribonucleotide Reductase (RNR), in Combination with High-Dose Cytarabine (HiDAC) in Relapsed and Refractory Acute Myeloid Leukemia (AML).”

The presentation discussed the safety and efficacy data from the recently completed phase II clinical trial, which was conducted at six major U.S. cancer centers.

The phase II study involved 25 patients under 60 years of age with relapsed or refractory AML treated with HiDAC and LOR-2040. According to the press release, 28 percent of the patients achieved complete remission (CR) or CR with incomplete blood count recovery (CRi) while one patient (4 percent) achieved partial remission.

AGR Tools, Inc. (AGRT) Awarded $230,000 Contract

AGR Inc., a global leader in the contract manufacturing & distribution of diamond tools and adhesives, announced today that subsidiary AGR Stone and Tools USA, Inc. (AGR USA) has won its first open bid contract since the acquisition of the company was completed at the end of May.
Rock Rutherford, President and CEO of both AGR and AGR USA, commented, “We are extremely pleased that our name recognition and quality have started to receive the attention of cost bidders,” Mr. Rutherford continued, “This initial customer order consists of $230,000 of asphalt blades which are to be delivered over the next ten months. This one contract is equal to over 40% of our entire annual gross revenue for 2009. We really are beginning to see the results of marketing efforts and expect to be seeing more bid contracts coming our way in the near future.”

Based in Conroe, TX, AGR specializes in producing consumable tools for the natural stone, engineered stone, concrete and masonry industries. AGR has nine contract factories in China that produce over 700 products for the diamond tool and construction industries. Primarily, AGR’s customers are located in Europe and Asia where AGR has maintains a nice size market share. The products were unable to be marketed in the United States due to contractual obligations previously. Recently the contracts that prohibited marketing in North America have expired and this has opened the doors for AGR to aggressively start pursuing North American customers. The North American diamond tool market is estimated to generate over $4 billion annually.

Since AGR began directing marketing efforts in North America in July of 2009, they have expanded their distribution network to service 31 markets across the US and Canada, approximately 25% of the United States. The goal of complete coverage is targeted by AGR over the next two years. With regards to the immediate future of their marketing strategy, Mr. Rutherford stated, “(the) US diamond tool market is extensive and we are now aggressively developing our dealership network focusing on the large key markets of Southern California, New York, and Florida. We expect to have dealers selected for those areas later this year.”

More information on AGR Inc. and their subsidiaries is available on the AGR corporate website at www.agrtools.com.


Sponsors of the Day


The QualityStocks Public Company Sponsor News

Micro Identification Technologies Inc. (MIT) (MMTC) MIT Contracts OSI Optoelectronics to Manufacture the MIT 1000 Rapid Microbial Identification System



About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

Home | Blog | Video | Market Basics | Media | Partners | Clients | About Us | Contact Us | Disclaimer | Unsubscribe
Copyright 2006-2009 QualityStocks 3370 N. Hayden Rd. Suite 123-591 Scottsdale, AZ 85251 480-374-1336